Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2461505 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL13985320 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL18937991 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL247528 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL13239640 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL23097490 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL16209782 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL9682360 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL20691112 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL14228823 | 1.00 | CHRM5 (0.35) | CHRM5CHRM1CHRM3CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394434-B2 | SCF extract containing cardiac glycoside | PHOENIX BIOTECHNOLOGY, INC. (US) | 2013-03-12 | — | — | US | disclosed |
| US-20120219620-A1 | SCF Extract Containing Cardiac Glycoside | PHOENIX BIOTECHNOLOGY, INC. (US) | 2012-08-30 | — | — | US | disclosed |
| US-8187644-B2 | Mixing powdered oleander leaf with supercritical carbon dioxide above critical pressure and critical temperature; depressurization and cooling to give a separated extract mixture; recovering cardiac glycoside-containing extract which acts as an antiproliferative agent; solvent extraction | PHOENIX BIOTECHNOLOGY INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20080200401-A1 | SCF Extract Containing Cardiac Glycoside | PHOENIX BIOTECHNOLOGY, INC. (US) | 2008-08-21 | — | — | US | disclosed |
| WO-1993006227-A1 | KETOALDONIC ACIDS HAVING FORMED STEREOGENIC CENTERS OF R CONFIGURATION: METHODS AND COMPOSITIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-04-01 | — | — | WO | disclosed |